With pharmaceutical companies marching inexorably toward successfully developing a COVID-19 vaccine, debate has erupted over who will have the eventual rights of ownership and pricing

As the novel coronavirus continues to spread and affect people across the world, countries are beginning to use technology to try and limit the spread

As we enter week four since President Trump recognized the COVID-19 outbreak as a global pandemic and a national emergency,[1] many wonder when